Beacon Investment Advisory Services’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-240
Closed -$4.6K 845
2026
Q1
$4.6K Buy
+240
New +$5.21K ﹤0.01% 703
2025
Q1
Sell
-18,905
Closed -$681K 252
2024
Q4
$681K Sell
18,905
-13,705
-42% -$464K 0.03% 154
2024
Q3
$1.38M Sell
32,610
-970
-3% -$41.1K 0.06% 129
2024
Q2
$1.35M Sell
33,580
-2,883
-8% -$120K 0.06% 126
2024
Q1
$1.29M Sell
36,463
-1,467
-4% -$39.3K 0.06% 126
2023
Q4
$1.12M Sell
37,930
-4,031
-10% -$83.6K 0.05% 134
2023
Q3
$872K Sell
41,961
-779
-2% -$21.4K 0.04% 153
2023
Q2
$1.05M Buy
42,740
+17,326
+68% +$557K 0.05% 152
2023
Q1
$1.03M Sell
25,414
-3,710
-13% -$154K 0.05% 147
2022
Q4
$1.31M Buy
29,124
+2,215
+8% +$100K 0.07% 136
2022
Q3
$1.29M Buy
26,909
+4,359
+19% +$239K 0.07% 134
2022
Q2
$1.33M Buy
22,550
+1,126
+5% +$92.4K 0.07% 137
2022
Q1
$2.49M Buy
21,424
+1,622
+8% +$189K 0.11% 121
2021
Q4
$2.98M Buy
19,802
+1,618
+9% +$218K 0.12% 121
2021
Q3
$2.17M Buy
18,184
+3,568
+24% +$393K 0.09% 130
2021
Q2
$1.42M Buy
14,616
+1,725
+13% +$154K 0.06% 151
2021
Q1
$1.14M Buy
12,891
+3,487
+37% +$324K 0.05% 156
2020
Q4
$900K Buy
9,404
+3,092
+49% +$319K 0.04% 155
2020
Q3
$716K Buy
6,312
+407
+7% +$42.8K 0.04% 154
2020
Q2
$584K Buy
5,905
+1,509
+34% +$120K 0.03% 160
2020
Q1
$283K Buy
+4,396
New +$308K 0.02% 199

Other funds holding TNDM

Beacon Investment Advisory Services's TNDM Position: Q2 2026 in Review

Beacon Investment Advisory Services sold out of Tandem Diabetes Care (TNDM) in Q2 2026, closing a stake of 240 shares — an estimated $4.6K sold.

Beacon Investment Advisory Services first reported a position in TNDM in Q1 2020 and held it in 21 quarters. The position peaked at $2.98M in Q4 2021. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Beacon Investment Advisory Services reported no remaining Tandem Diabetes Care position as of Q2 2026 after selling out during the quarter.
  • Beacon Investment Advisory Services sold 240 Tandem Diabetes Care shares in Q2 2026, an estimated $4.6K.
  • Beacon Investment Advisory Services first reported a position in Tandem Diabetes Care in Q1 2020 and held it in 21 quarters.
  • Beacon Investment Advisory Services's Tandem Diabetes Care position peaked at $2.98M in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Beacon Investment Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.